Idiopathic Pulmonary Fibrosis

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2013) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,642

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.

MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline

Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916

Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis

The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,654

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444

Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357

A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329

NMDA receptor activation induces damage of alveolar type II cells and lung fibrogenesis through ferroptosis

Cheng, H., Feng, D., Li, X., Gao, L., Qiu, Y.-J., Liang, X.-Y., Zhou, Y., Huang, P., Shao, M., Zhang, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119535 · Cited by 22

Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis

Lee, C. H., Kwak, S. H., Han, J., Shin, J. H., Yoo, B., Lee, Y. S., Park, J. S., Lim, B. J., Lee, J. G., Kim, Y. S., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.00580-2023 · Cited by 22

Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide study

Kim, J., Chun, J., Lee, C., Han, K., Choi, S., Lee, J., Soh, H., Choi, K., Park, S., Kang, E. A., et al. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14838 · Cited by 22

Multidisciplinary management of interstitial lung diseases: A real-life study.

Biglia, C., Ghaye, B., Reychler, G., Koenig, S., Yıldız, H., Lacroix, V., Tamirou, F., Hoton, D., Pieters, T., & Froidure, A. (2019) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v36i2.8107 · Cited by 25

Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Huang, T., Kuo, C., Chen, C., Tseng, Y., Wu, C., & Lin, S. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01530-6 · Cited by 24

CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1α-mediated lactate production

Yan, P., Yang, K., Xu, M., Zhu, M., Duan, Y., Li, W., Liu, L., Liang, C., Li, Z., Pan, X., et al. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae021 · Cited by 23

The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs

Zhang, M., Wang, J., Liu, R., Wang, Q., Qin, S., Chen, Y., & Li, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37326 · Cited by 22

Global health inequalities in the burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2021

Chen, S., & Li, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-20430-y · Cited by 21

Familial Interstitial Lung Disease

Kropski, J. A. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1708054 · Cited by 22

Long Noncoding RNA FENDRR Inhibits Lung Fibroblast Proliferation via a Reduction of β-Catenin

Senavirathna, L. K., Liang, Y., Huang, C., Yang, X., Bamunuarachchi, G., Xu, D., Dang, Q., Sivasami, P., Vaddadi, K., Munteanu, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168536 · Cited by 21

Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases

Mammoliti, O., Jansen, K., Bkassiny, S. E., Palisse, A., Triballeau, N., Bucher, D., Allart, B., Jaunet, A., Tricarico, G. A., Wachter, M. D., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01066 · Cited by 22

Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study

Lee, E. G., Lee, T.-H., Hong, Y., Ryoo, J., Heo, J. W., Gil, B. M., Kang, H. S., Kwon, S. S., & Kim, Y. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261684 · Cited by 24

Number 2 Feibi Recipe Inhibits H2O2-Mediated Oxidative Stress Damage of Alveolar Epithelial Cells by Regulating the Balance of Mitophagy/Apoptosis

Gu, X., Long, Q., Wei, W., Tong, J., Li, Z., Zhang, Z., & Jiao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.830554 · Cited by 21

Endothelial Cell Senescence Exacerbates Pulmonary Fibrosis Potentially Through Accelerated Endothelial to Mesenchymal Transition.

Ramadhiani, R., Ikeda, K., Hirata, K., & Emoto, N. (2021) · PubMed Central · doi:10.24546/81013008 · Cited by 21

The influence of green tea extract on nintedanib’s bioavailability in patients with pulmonary fibrosis

Veerman, G., van der Werff, S. C., Koolen, S. L. W., Miedema, J., Hoop, E. O., van der Mark, S. C., Chandoesing, P. P., de Bruijn, P., Wijsenbeek, M. S., & Mathijssen, R. H. J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113101 · Cited by 22

Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols

Patel, H., Shah, J. R., Patel, D., Avanthika, C., Jhaveri, S., & Gor, K. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101484 · Cited by 21

An Inhibitory Function of TRPA1 Channels in TGF-β1–driven Fibroblast-to-Myofibroblast Differentiation

Geiger, F., Zeitlmayr, S., Staab-Weijnitz, C. A., Rajan, S., Breit, A., Gudermann, T. W., & Dietrich, A. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0159oc · Cited by 21

The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis

Jeon, S., Jin, H. K., Kim, J., Hur, Y., Song, E. J., Lee, Y., Na, Y., Cho, J., & Lee, Y. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00896-5 · Cited by 21

Prognostic value of deep learning–based fibrosis quantification on chest CT in idiopathic pulmonary fibrosis

Nam, J. G., Choi, Y., Lee, S., Yoon, S. H., Goo, J. M., & Kim, H. (2023) · European Radiology · doi:10.1007/s00330-023-09534-y · Cited by 22

Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression

Inoue, R., Yasuma, T., D’Alessandro, V. F., Toda, M., Ito, T., Tomaru, A., D’Alessandro‐Gabazza, C. N., Tsuruga, T., Okano, T., Takeshita, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076695 · Cited by 21

Pharmacological approaches to pulmonary fibrosis following COVID-19

Laššán, Š., Tesař, T., Tisonova, J., & Laššánová, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1143158 · Cited by 20

A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis

Zhao, T., Gong, B., Luo, S., Zhang, R., Zhang, L., Huang, Y., Gao, H., & Gong, T. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.024 · Cited by 23

Machine Learning and Single-Cell Analysis Identify Molecular Features of IPF-Associated Fibroblast Subtypes and Their Implications on IPF Prognosis

Hou, J., Yang, Y., & Han, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010094 · Cited by 22

Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease

Wheeler, A. M., Baker, J. F., Riley, T. R., Yang, Y., Roul, P., Wysham, K. D., Cannon, G. W., Kunkel, G. A., Kerr, G. S., Ascherman, D. P., et al. (2024) · Rheumatology · doi:10.1093/rheumatology/keae001 · Cited by 24

Bioinformatic analysis of next‑generation sequencing data to identify dysregulated genes in fibroblasts of idiopathic pulmonary fibrosis

Sheu, C., Chang, W., Tsai, M., Liao, S., Chong, I., & Kuo, P. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4086 · Cited by 21

The Extracellular Matrix Enriched With Exosomes for the Treatment on Pulmonary Fibrosis in Mice

Yu, Y., Liu, X., Zhao, Z., Xu, Z., Qiao, Y., Zhou, Y., Qiao, H., Zhong, J., Dai, J., & Suo, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.747223 · Cited by 22

Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall

Sellarés, J., & Rojas, M. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0267ed · Cited by 22

Translating Idiopathic pulmonary fibrosis guidelines into clinical practice

Cordeiro, C. R., & Morais, A. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2020.05.017 · Cited by 20

Circulating microRNA Signature Associated to Interstitial Lung Abnormalities in Respiratory Asymptomatic Subjects

Ortíz-Quintero, B., Buendía-Roldán, I., Ramírez-Salazar, E. G., Balderas-Martínez, Y. I., Ramírez-Rodriguez, S. L., Martínez‐Espinosa, K., & Selman, M. (2020) · Cells · doi:10.3390/cells9061556 · Cited by 22

Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases

Kershaw, C. D., Batra, K., Torrealba, J. R., & Terada, L. S. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106400 · Cited by 21

The antifibrotic effect of pheretima protein is mediated by the TGF-β1/Smad2/3 pathway and attenuates inflammation in bleomycin-induced idiopathic pulmonary fibrosis

Li, S., Yang, Q., Chen, F., Tian, L., Huo, J., Meng, Y., Tang, Q., & Wang, W. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114901 · Cited by 20

Influence of S100A2 in Human Diseases

Sugino, H., & Sawada, Y. (2022) · Diagnostics · doi:10.3390/diagnostics12071756 · Cited by 21

Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis

Egea-Zorrilla, A., Vera, L., Sáez, B., & Pardo–Saganta, A. (2022) · Cells · doi:10.3390/cells11162595 · Cited by 21

Role of Circular RNAs in Pulmonary Fibrosis

Zhou, J. P., Chen, Y., He, M., Li, X., & Wang, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810493 · Cited by 21

Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice

Wang, H., Zhang, J., Zhang, X., Zhao, N., Zhou, Z., Tao, L., Fu, L., Peng, S., & Chai, J. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166556 · Cited by 20

Therapeutic potential for P2Y2 receptor antagonism

Jasmer, K. J., Forti, K. M., Woods, L. T., Cha, S., & Weisman, G. A. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09900-3 · Cited by 21

Cellular and Molecular Control of Lipid Metabolism in Idiopathic Pulmonary Fibrosis: Clinical Application of the Lysophosphatidic Acid Pathway

Nakamura, Y., & Shimizu, Y. (2023) · Cells · doi:10.3390/cells12040548 · Cited by 20

Effects of Resveratrol on Pulmonary Fibrosis via TGF-β/Smad/ERK Signaling Pathway

Liu, L., Liu, B., Li, L., Zhou, X., & Li, Q. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500313 · Cited by 20

4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition

Wu, Y., Zhang, Y., Jiang, F., He, S., Zhang, Y., Chen, D., Tong, Y., Nie, Y., & Pang, Q. (2023) · Inflammation Research · doi:10.1007/s00011-023-01733-z · Cited by 21

Panax notoginseng saponin alleviates pulmonary fibrosis in rats by modulating the renin-angiotensin system

Li, H., Wang, Y., Chen, T., Gao, Y., Ling, S., Yang, Y., Gao, Y., Huo, W., & Zhang, G. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116979 · Cited by 20

Crystal ribcage: a platform for probing real-time lung function at cellular resolution

Banerji, R., Grifno, G. N., Shi, L., Smolen, D., LeBourdais, R., Muhvich, J., Eberman, C., Hiller, B. E., Lee, J., Regan, K., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-02004-9 · Cited by 24

Trichodelphinine A alleviates pulmonary fibrosis by inhibiting collagen synthesis via NOX4-ARG1/TGF-β signaling pathway

Liu, F., Yao, Y., Guo, C., Dai, P., Huang, J., Peng, P., Wang, M., Dawa, Z., Zhu, C., & Lin, C. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155755 · Cited by 20

Gas6-Axl signal promotes indoor VOCs exposure-induced pulmonary fibrosis via pulmonary microvascular endothelial cells–fibroblasts cross-talk

Liu, Q., Niu, Y., Pei, Z., Yang, Y., Xie, Y., Wang, M., Wang, J., Wu, M., Zheng, J., Yang, P., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134786 · Cited by 20

Delineating, Imaging, and Assessing Pulmonary Fibrosis Remodeling via Collagen Hybridization

Zhao, J., Yu, W., Zhou, D., Liu, Y., Wei, J., Bi, L., Zhao, S., He, J., Liu, J., Su, J., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c06139 · Cited by 22

Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications

Jadamba, B., Jin, Y., & Lee, H. (2024) · European Respiratory Review · doi:10.1183/16000617.0272-2023 · Cited by 23

Occupational exposures and idiopathic pulmonary fibrosis

Walters, G. I. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000610 · Cited by 20

MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)

Shochet, G. E., Israeli‐Shani, L., Kains, I., Wand, O., & Shitrit, D. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01377-3 · Cited by 20

Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover

Sésé, L., Caliez, J., Annesi‐Maesano, I., Cottin, V., Pesce, G., Didier, M., Carton, Z., Israël‐Biet, D., Crestani, B., Guillot-Dudoret, S., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106415 · Cited by 20

Global research hotspots and research trends on idiopathic pulmonary fibrosis: a bibliometric and visualization analysis

Ma, Y., Zhou, R., & Wu, Q. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1836 · Cited by 20

Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes

Iyoda, A., Azuma, Y., Sakamoto, S., Homma, S. A., & Sano, A. (2021) · Surgery Today · doi:10.1007/s00595-021-02343-0 · Cited by 20

GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells

Fernandez, R. J., Gardner, Z., Slovik, K. J., Liberti, D. C., Estep, K. N., Yang, W., Chen, Q., Santini, G. T., Perez, J. V., Root, S., et al. (2022) · eLife · doi:10.7554/elife.64430 · Cited by 19

Antibody-based therapies for idiopathic pulmonary fibrosis

Sgalla, G., Flore, M., Siciliano, M., & Richeldi, L. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1735346 · Cited by 22

Targeting the Myofibroblast in Pulmonary Fibrosis

Misharin, A. V., & Budinger, G. R. S. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1037ed · Cited by 20

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases

Theodoropoulou, M. A., Mantzourani, C., & Kokotos, G. (2024) · Biomolecules · doi:10.3390/biom14121605 · Cited by 19

Distinct mural cells and fibroblasts promote pathogenic plasma cell accumulation in idiopathic pulmonary fibrosis

Yang, Z., Cao, G., Tan, X., Orfanos, S., Jude, J. A., Barbet, G., An, S. S., Jiang, D., Panettieri, R. A., & Yang, Q. (2025) · European Respiratory Journal · doi:10.1183/13993003.01114-2024 · Cited by 20

Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease

Koyauchi, T., Yasui, H., Enomoto, N., Hasegawa, H., Hozumi, H., Suzuki, Y., Karayama, M., Furuhashi, K., Fujisawa, T., Nakamura, Y., et al. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620906327 · Cited by 19

Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs

Matsuda, S., Kim, J., Sugiyama, F., Matsuo, Y., Ishida, J., Murata, K., Nakamura, K., Namiki, K., SUDO, T., Kuwaki, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186746 · Cited by 18

A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis

Németh, J., Schundner, A., Quast, K., Winkelmann, V. E., & Frick, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.567675 · Cited by 20

Tianlongkechuanling Inhibits Pulmonary Fibrosis Through Down-Regulation of Arginase-Ornithine Pathway

Zhang, L., Qu, S., Wang, L., Wang, C., Yu, Q., Zhang, Z., Diao, Y., Zhang, B., Li, Y., Shi, Y., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.661129 · Cited by 20

Citrus alkaline extracts prevent endoplasmic reticulum stress in type II alveolar epithelial cells to ameliorate pulmonary fibrosis via the ATF3/PINK1 pathway

Wang, Z., Feng, F., He, H., Wu, Q., Gu, C., Hrovat, J., Peng, W., Xu, Y., Han, D., Yang, P., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153599 · Cited by 19

LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation

Chen, T., Guo, Y., Wang, J., Ai, L., Ma, L., He, W., Li, Z., Yu, X., Li, J., Fan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03884-5 · Cited by 19

Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects Against Pulmonary Fibrosis

Luzina, I. G., Rus, V., Lockatell, V., Courneya, J.-P., Hampton, B., Fishelevich, R., Misharin, A. V., Todd, N. W., Badea, T. C., Rus, H., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0022oc · Cited by 19

BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact

Sadeleer, L. D., Verleden, S. E., Schupp, J. C., McDonough, J. E., Goos, T., Yserbyt, J., Bargagli, E., Rottoli, P., Kaminski, N., Prasse, A., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2021.12.668 · Cited by 20

The Role of Extracellular Vesicles in Idiopathic Pulmonary Fibrosis Progression: An Approach on Their Therapeutics Potential

Ramírez-Hernández, A. A., Velázquez-Enríquez, J. M., Santos-Álvarez, J. C., López-Martínez, A., Reyes-Jiménez, E., Torres, G., González-García, K., Vásquez-Garzón, V. R., & Baltiérrez‐Hoyos, R. (2022) · Cells · doi:10.3390/cells11040630 · Cited by 19

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway

Li, Z., Geng, J., Xie, B., He, J., Wang, J., Peng, L., Hu, Y., Dai, H., & Wang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.834604 · Cited by 19

Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis

Chen, I., Liu, Y., Wu, Y.-H., Lo, S., Dai, Z., Hsu, J., & Tseng, Y. (2022) · Cells · doi:10.3390/cells11091543 · Cited by 19

The sialidase NEU3 promotes pulmonary fibrosis in mice

Pilling, D., Sahlberg, K., Karhadkar, T. R., Chen, W., & Gomer, R. H. (2022) · Respiratory Research · doi:10.1186/s12931-022-02146-y · Cited by 17

The potential role of interleukin (IL)‐25/IL‐33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis

Xu, X., Dai, H., & Zhang, J. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13541 · Cited by 18

Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies

Dai, X., Yang, Z., Zhang, W., Liu, S., Zhao, Q., Liu, T., Chen, L., Li, L., Wang, Y., & Shao, R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.959010 · Cited by 19

Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling

Li, J., Li, K., Tian, Y., Zhao, P., Liu, X., Li, M., & Bai, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154604 · Cited by 19

DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts

Lai, X., Huang, S., Lin, Y., Qiu, Y., Pu, L., Lin, S., Zeng, Q., Huang, W., & Wang, Z. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.324 · Cited by 20

Pulmonary fibrosis in patients with COVID-19: A retrospective study

Li, F., Deng, J., Song, Y., Wu, C., Yu, B., Wang, G., Li, J., Zhong, Y., & Liang, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1013526 · Cited by 19

Qimai Feiluoping decoction inhibits mitochondrial complex I-mediated oxidative stress to ameliorate bleomycin-induced pulmonary fibrosis

Ding, L., Yang, Y., Wang, Z., Su, H., Li, Y., Ma, J., Bao, T., Qi, H., Song, S., Li, J., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154707 · Cited by 19

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis

Li, J.-M., Chang, W., Li, L., Yang, D. C. H., Hsu, S., Kenyon, N. J., & Chen, C. (2023) · Respiratory Research · doi:10.1186/s12931-023-02421-6 · Cited by 23

The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis

Lee, S. Y., Park, S., Lee, S., Kim, H., Kwon, J.-H., Yoo, J., Kim, K., Park, M. S., Lee, C. G., Elias, J. A., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01066-1 · Cited by 22

Design, Development, and In Vitro Characterization of Pirfenidone-Loaded Biodegradable Nanoparticles for Idiopathic Pulmonary Fibrosis

Dudhat, K. R., Patel, H. V., & Mori, D. (2023) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-023-09763-0 · Cited by 19

Alveolar macrophage modulation via the gut–lung axis in lung diseases

Chen, Z., Liu, Y., & Huang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1279677 · Cited by 19

The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study

Zhao, R., Xie, B., Wang, X., Zhang, X., Ren, Y., Wang, C., & Dai, H. (2024) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2024.102287 · Cited by 22

O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis

Vang, S., Helton, E. S., Guo, Y., Burpee, B., Rose, E., Easter, M., Bollenbecker, S., Hirsch, M. J., Matthews, E. L., Jones, L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387197 · Cited by 18

Plumbagin Suppresses Pulmonary Fibrosis via Inhibition of p300 Histone Acetyltransferase Activity

Lee, S. Y., Kim, M. J., Jang, S., Lee, G.-E., Hwang, S., Kwon, Y., Hong, J. Y., Sohn, M. H., Park, S., & Yoon, H. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4670 · Cited by 19

Integrated Analysis of a Gene Correlation Network Identifies Critical Regulation of Fibrosis by lncRNAs and TFs in Idiopathic Pulmonary Fibrosis

Wang, F., Li, P., & Li, F. (2020) · BioMed Research International · doi:10.1155/2020/6537462 · Cited by 19

Transcriptomic changes involved in the dedifferentiation of myofibroblasts derived from the lung of a patient with idiopathic pulmonary fibrosis

Suzuki, K., Kim, J., Ugai, K., Matsuda, S., Mikami, H., Yoshioka, K., Ikari, J., Hatano, M., Fukamizu, A., Tatsumi, K., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11218 · Cited by 19

Associations of ω-3 Fatty Acids With Interstitial Lung Disease and Lung Imaging Abnormalities Among Adults

Kim, J. S., Steffen, B. T., Podolanczuk, A. J., Kawut, S. M., Noth, I., Raghu, G., Michos, E. D., Hoffman, E. A., Axelsson, G. T., Guðmundsson, G., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa168 · Cited by 17

Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis

Lambert, E. M., Wuyts, W. A., Yserbyt, J., & Sadeleer, L. D. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106259 · Cited by 19

Management of Idiopathic Pulmonary Fibrosis

Salisbury, M. L., & Wijsenbeek, M. S. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.03.004 · Cited by 20

A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes

Qiu, L., Gong, G., Wu, W., Li, N., Li, Z., Chen, S., Li, P., Chen, T., Zhao, H., Hu, C., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4545 · Cited by 18

Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis

Majewski, S., Szewczyk, K., Jerczyńska, H., Miłkowska-Dymanowska, J., Białas, A. J., Gwadera, Ł., & Piotrowski, W. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.760776 · Cited by 21

Radiomics for the Prediction of Response to Antifibrotic Treatment in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study

Yang, C.-C., Chen, C., Kuo, Y., Ko, C., Wu, W.-J., Liang, C.-H., Yun, C., & Huang, W. (2022) · Diagnostics · doi:10.3390/diagnostics12041002 · Cited by 19

Comprehensive epigenomic profiling of human alveolar epithelial differentiation identifies key epigenetic states and transcription factor co-regulatory networks for maintenance of distal lung identity

Zhou, B., Stueve, T. R., Mihalakakos, E. A., Miao, L., Mullen, D. J., Wang, Y., Liu, Y., Luo, J., Tran, E., Siegmund, K. D., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-08152-6 · Cited by 18

Extracellular Vesicles as Unique Signaling Messengers: Role in Lung Diseases

Gao, Y., & Raj, J. U. (2020) · Comprehensive physiology · doi:10.1002/cphy.c200006 · Cited by 21

Stimuli-Specific Senescence of Primary Human Lung Fibroblasts Modulates Alveolar Stem Cell Function

Melo-Narváez, M. C., Bramey, N., See, F., Heinzelmann, K., Ballester, B., Steinchen, C., Jain, E., Federl, K., Hu, Q., Dhakad, D., et al. (2024) · Cells · doi:10.3390/cells13131129 · Cited by 18

Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases

Aringer, M., Distler, O., Hoffmann‐Vold, A., Kuwana, M., Prosch, H., & Volkmann, E. R. (2024) · RMD Open · doi:10.1136/rmdopen-2024-004704 · Cited by 21

Single Cell RNA ‐Seq Identifies Cell Subpopulations Contributing to Idiopathic Pulmonary Fibrosis in Humans

Zhang, T., Hou, Z., Ding, Z., Wang, P., Pan, X., & Li, X. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70402 · Cited by 18

The role of oxidative stress-related genes in idiopathic pulmonary fibrosis

Zhao, W., Bai, B., Li, H., Feng, Y., Sun, J., Yang, F., Zheng, P., & Zhang, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-89770-y · Cited by 27

Idiopathic pulmonary fibrosis: shifting the concept to irreversible pulmonary fibrosis of many entities

Raghu, G. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30311-x · Cited by 18

Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder

Giri, N., Ravichandran, S., Wang, Y., Gadalla, S. M., Alter, B. P., Fontana, J. R., & Savage, S. A. (2019) · ERJ Open Research · doi:10.1183/23120541.00209-2019 · Cited by 20

Relationship between air pollution levels in Madrid and the natural history of idiopathic pulmonary fibrosis: severity and mortality

Aguilar, P. M., Carrera, L. G., Carpio, C., Sánchez, M. I. T., Peña, M. F.-V., Hernán, G. B., Rodríguez, I. E., Regojo, R. M., Zamarrón, E., Álvarez, P. D.-A., et al. (2021) · Journal of International Medical Research · doi:10.1177/03000605211029058 · Cited by 20

RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway

Calabrese, F., Lunardi, F., Tauro, V., Pezzuto, F., Fortarezza, F., Vedovelli, L., Faccioli, E., Balestro, E., Schiavon, M., Esposito, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063323 · Cited by 18

An Airway-Centric View of Idiopathic Pulmonary Fibrosis

Stancil, I. T., Michalski, J. E., & Schwartz, D. A. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2219pp · Cited by 18

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease

Choi, J. Y., Song, J. W., & Rhee, C. K. (2022) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2021.0141 · Cited by 18

Update on diagnosis and treatment of idiopathic pulmonary fibrosis

Martínez, J. A. B., Baldi, B. G., da Costa, C. H., Jezler, S. F. D. O., Lima, M. S., & Rufino, R. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000000152 · Cited by 39

Idiopathic pulmonary fibrosis: an Australian perspective

Prasad, J. D., Holland, A. E., Glaspole, I., & Westall, G. P. (2016) · Internal Medicine Journal · doi:10.1111/imj.13078 · Cited by 10

Management of Idiopathic Pulmonary Fibrosis

Fioret, D., Roman, J., & Perez, R. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821fbdbc · Cited by 10

Lung transplantation for idiopathic pulmonary fibrosis

Pavec, J. L., Dauriat, G., Gazengel, P., Dolidon, S., Hanna, A., Feuillet, S., Pradère, P., Crutu, A., Florea, V., Boulate, D., et al. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2020.104026 · Cited by 29

[Diagnostic criteria and possible treatment of idiopathic pulmonary fibrosis].

Bendstrup, E. M., Hyldgaard, C., & Hilberg, O. (2014) · PubMed · Cited by 2